TRV GP III, LLC
- SEC CIK
- 0001637299
- Latest filing
- Feb 14, 2024
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 11, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 7
- 0 vs. Q1 2021
- Portfolio value
- $572.8M
- −$217.8M (−27.5%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | COM | 5,524,031 | $175.3M | 30.6% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 5,839,160 | $170.0M | 29.7% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 3,422,549 | $90.8M | 15.9% | −1,085,784−24.1% | Reduced | History |
| FULCFulcrum Therapeutics, Inc. | COM | 5,962,202 | $62.5M | 10.9% | 00.0% | Unchanged | History |
| DBTXDecibel Therapeutics, Inc. | COM | 3,139,685 | $27.0M | 4.7% | 00.0% | Unchanged | History |
| VYGRVoyager Therapeutics, Inc. | COM | 6,391,176 | $26.4M | 4.6% | 00.0% | Unchanged | History |
| JNCEJounce Therapeutics, Inc. | COM | 3,048,780 | $20.7M | 3.6% | 00.0% | Unchanged | History |